Alvotech
NASDAQ Global MarketTotal Valuation
Alvotech carries a market capitalization of 1.27B, placing it among publicly traded companies globally. Its enterprise value stands at 1.39B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.27B |
| Enterprise Value | 1.39B |
Share Statistics
Alvotech currently has 312.15M shares outstanding.
| Shares Outstanding | 312.15M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Enterprise Valuation
On an enterprise value basis, Alvotech trades at an EV/EBITDA multiple of 11.89 and an EV/FCF ratio of 15.21. The EV/Sales ratio of 2.49 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 18.03 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.49 |
| EV / EBITDA | 11.89 |
| EV / EBIT | 18.03 |
| EV / FCF | 15.21 |
Financial Position
Alvotech maintains a current ratio of 1.76, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -516.20, indicating conservative leverage, while an interest coverage ratio of 0.82 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.76 |
| Quick Ratio | 0.76 |
| Debt / Equity | -516.20 |
| Debt / EBITDA | 12.44 |
| Interest Coverage | 0.82 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -6.05 |
| Return on Invested Capital (ROIC) | -13.52 |
| Return on Capital Employed (ROCE) | 33.42 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.17 |
Taxes
Over the trailing twelve months, Alvotech has paid 124.64M in income taxes, reflecting an effective tax rate of 283.84.
| Income Tax | 124.64M |
| Effective Tax Rate | 283.84 |
Stock Price Statistics
Alvotech's stock has declined approximately -89.14286% over the past 52 weeks. The 50-day moving average sits at 0.25, while the 200-day moving average is 0.62.
| Beta (5Y) | N/A |
| 52-Week Price Change | -89.14286% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.62 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached 117.18M, while operating income came in at 77.30M.
| Revenue | 559.42M |
| Gross Profit | 343.22M |
| Operating Income | 77.30M |
| Pretax Income | 43.91M |
| Net Income | -80.73M |
| EBITDA | 117.18M |
| EBIT | 77.30M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Alvotech holds 63.83M in cash and equivalents against 1.46B in total debt, resulting in a net debt position of 1.25B. Total book value stands at -2.41B, with working capital of 196.20M providing operational flexibility.
| Cash & Cash Equivalents | 63.83M |
| Total Debt | 1.46B |
| Net Debt | 1.25B |
| Equity (Book Value) | -2.41B |
| Book Value Per Share | N/A |
| Working Capital | 196.20M |
Cash Flow
Alvotech produced -123.17M in operating cash flow over the past twelve months.
| Operating Cash Flow | -123.17M |
| Capital Expenditures | -118.95M |
| Free Cash Flow | -242.13M |
| FCF Per Share | N/A |
Margins
Alvotech operates with a gross margin of 61.35, reflecting its pricing power and cost economics. The operating margin of 13.82 and net profit margin of -14.43 provide insight into operational efficiency.
| Gross Margin | 61.35 |
| Operating Margin | 13.82 |
| Pretax Margin | 7.85 |
| Profit Margin | -14.43 |
| EBITDA Margin | 20.95 |
Scores
Alvotech posts an Altman Z-Score of -1.80, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.80 |